Siemers Eric
Chief Medical Officer
Siemers Eric has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jan 23, 2026.
On the most recent filing, Siemers Eric is listed as Chief Medical Officer at Acumen Pharmaceuticals, Inc. Inside the rolling window, Siemers Eric reported no open-market purchases and 4 open-market sales totaling $27K in ABOS. The largest disclosed transaction in the window is a sale of 6,834 ABOS shares on Jan 6, 2026, worth $13K.
Companies traded
Other insiders at ABOS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$27K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Siemers Eric made?
Siemers Eric has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Siemers Eric trade?
Siemers Eric has filed SEC Form 4 disclosures for 1 company, including ABOS.
When was Siemers Eric's most recent SEC Form 4 filing?
Siemers Eric's most recent SEC Form 4 filing on Tracefour is dated Jan 23, 2026.
What is Siemers Eric's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Siemers Eric is listed as Chief Medical Officer.
What is Siemers Eric's total buy and sell value in the current window?
Inside the rolling retention window, Siemers Eric bought $0 and sold $27K based on SEC Form 4 filings.
What was Siemers Eric's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,834 ABOS shares on 2026-01-06, worth $13K, per SEC Form 4 filings.